GSK Scientists Knew About Zantac’s Cancer Risks For Forty Years

Zero Hedge, Released on 2/20/23

Three years after the Food & Drug Administration (FDA) pulled GSK Plc’s heartburn drug Zantac off the market due to suspected links to cancer, and just two weeks before the trial

Continue…

Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments